BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  ESTECH Signs Distribution Agreement With Neoprobe Corporation

  June 12, 2006

   · 

  1 min read
• Drug Development

  Daiichi Sankyo, Inc. Release: First Clinical Trial To Demonstrate Colesevelam HCl Plus Stable Oral Antidiabetic Medication Improves Glycemic Control In Patients With Type 2 Diabetes

  June 12, 2006

   · 

  1 min read
• Drug Development

  Newly Released Phase III Studies For JANUVIA(TM), Merck & Co., Inc.'s Investigational Once-Daily Medicine For Type 2 Diabetes, Showed Significantly Reduced Blood Sugar Levels When Used As Monotherapy Or As Add-On Treatment

  June 12, 2006

   · 

  1 min read
• BioCapital

  American Diabetes Association Release: Doctors Failing To Intensify Needed Therapy In People With Diabetes

  June 12, 2006

   · 

  1 min read
• Drug Development

  Eli Lilly and Company, Alkermes. Amylin Pharmaceuticals, Inc. Release: Study Demonstrated Once-Weekly Exenatide LAR Improved Glucose Control ln Patients With Type 2 Diabetes

  June 12, 2006

   · 

  1 min read
• Drug Development

  Merck & Co., Inc. And Schering-Plough Corporation Release: New Study Showed VYTORIN(R) Superior To Lipitor In Reducing LDL ‘Cholesterol In Patients With Type II Diabetes At The Recommended Usual Starting Doses

  June 12, 2006

   · 

  9 min read
• BioCapital

  Eli Lilly and Company And Amylin Pharmaceuticals, Inc. Release: New Study Illustrates Economic Benefit Of Weight Loss In People With Type 2 Diabetes

  June 12, 2006

   · 

  1 min read
• Drug Development

  Late Breaking Data At American Diabetes Association 2006 Shows Amylin Pharmaceuticals, Inc.-Leptin Co-Administration Reduces Body Weight And Body Fat In Animal Studies

  June 12, 2006

   · 

  1 min read
• OccuLogix Inc. Reports On Meeting With FDA; Agency Requires Additional Study Of The RHEO(TM) System

  June 12, 2006

   · 

  2 min read
• BioCapital

  Sanofi-Aventis (New Jersey) Release: New Study Shows An Innovative Mealtime Insulin Dosing Algorithm May Provide A Safe And Effective Alternative To Carbohydrate Counting For Patients With Type 2 Diabetes

  June 12, 2006

   · 

  1 min read